GLAD: Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
Public ClinicalTrials.gov record NCT00280865. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Dose-Finding, Efficacy, and Safety of AZ 242 (Tesaglitazar) in Subjects With Type 2 Diabetes
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a 12-week randomized, double-blind, multi-center, active-controlled (open-label pioglitazone) and placebo-controlled study of tesaglitazar (0.1, 0.5, 1, 2, and 3 mg) in patients with type 2 diabetes, not adequately controlled on diet and lifestyle advice alone during the run-in period. The study comprises a 2-week enrollment period, 4 week placebo single blind run in period followed by a 12-week double blind treatment period and a 3-week follow-up period
Study identification
- NCT ID
- NCT00280865
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 500 participants
Conditions and interventions
Conditions
Interventions
- Tesaglitazar Drug
- Pioglitazone Drug
- Dietary and Lifestyle Modification Counseling Behavioral
Drug · Behavioral
Eligibility (public fields only)
- Age range
- 30 Years to 50 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2002 (Type not available)
- Primary completion
- Not listed
- Completion
- Jun 2003 (Type not available)
- Last update posted
- Jul 31, 2006
2002 – 2003
United States locations
- U.S. sites
- 90
- U.S. states
- 35
- U.S. cities
- 90
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | — | — |
| Research Site | Huntsville | Alabama | — | — |
| Research Site | Montgomery | Alabama | — | — |
| Research Site | Mesa | Arizona | — | — |
| Research Site | Phoenix | Arizona | — | — |
| Research Site | Tucson | Arizona | — | — |
| Research Site | Alhambra | California | — | — |
| Research Site | Anaheim | California | — | — |
| Research Site | Dinuba | California | — | — |
| Research Site | Escondido | California | — | — |
| Research Site | Fresno | California | — | — |
| Research Site | Greenbrae | California | — | — |
| Research Site | Long Beach | California | — | — |
| Research Site | Mission Viejo | California | — | — |
| Research Site | Orange | California | — | — |
| Research Site | Sacramento | California | — | — |
| Research Site | San Diego | California | — | — |
| Research Site | Walnut Creek | California | — | — |
| Research Site | Stamford | Connecticut | — | — |
| Research Site | Waterbury | Connecticut | — | — |
| Research Site | Washington D.C. | District of Columbia | — | — |
| Research Site | Brandon | Florida | — | — |
| Research Site | Coral Gables | Florida | — | — |
| Research Site | DeLand | Florida | — | — |
| Research Site | Gainesville | Florida | — | — |
| Research Site | Hollywood | Florida | — | — |
| Research Site | Miami | Florida | — | — |
| Research Site | Atlanta | Georgia | — | — |
| Research Site | Augusta | Georgia | — | — |
| Research Site | Blue Ridge | Georgia | — | — |
| Research Site | Dunwoody | Georgia | — | — |
| Research Site | Gurnee | Illinois | — | — |
| Research Site | Springfield | Illinois | — | — |
| Research Site | Evansville | Indiana | — | — |
| Research Site | Indianapolis | Indiana | — | — |
| Research Site | Wichita | Kansas | — | — |
| Research Site | Louisville | Kentucky | — | — |
| Research Site | New Orleans | Louisiana | — | — |
| Research Site | Bangor | Maine | — | — |
| Research Site | Baltimore | Maryland | — | — |
| Research Site | Salisbury | Massachusetts | — | — |
| Research Site | Worcester | Massachusetts | — | — |
| Research Site | Ann Arbor | Michigan | — | — |
| Research Site | Cadillac | Michigan | — | — |
| Research Site | Jackson | Mississippi | — | — |
| Research Site | St Louis | Missouri | — | — |
| Research Site | Omaha | Nebraska | — | — |
| Research Site | Henderson | Nevada | — | — |
| Research Site | Las Vegas | Nevada | — | — |
| Research Site | Pahrump | Nevada | — | — |
| Research Site | Lawrenceville | New Jersey | — | — |
| Research Site | Newark | New Jersey | — | — |
| Research Site | Albany | New York | — | — |
| Research Site | Brooklyn | New York | — | — |
| Research Site | Buffalo | New York | — | — |
| Research Site | New Hyde Park | New York | — | — |
| Research Site | New York | New York | — | — |
| Research Site | Charlotte | North Carolina | — | — |
| Research Site | Hickory | North Carolina | — | — |
| Research Site | Winston-Salem | North Carolina | — | — |
| Research Site | Canfield | Ohio | — | — |
| Research Site | Cincinnati | Ohio | — | — |
| Research Site | Columbus | Ohio | — | — |
| Research Site | Kettering | Ohio | — | — |
| Research Site | Lakewood | Ohio | — | — |
| Research Site | Oklahoma City | Oklahoma | — | — |
| Research Site | Eugene | Oregon | — | — |
| Research Site | Altoona | Pennsylvania | — | — |
| Research Site | Cheswick | Pennsylvania | — | — |
| Research Site | Penndel | Pennsylvania | — | — |
| Research Site | Philadelphia | Pennsylvania | — | — |
| Research Site | Warminster | Pennsylvania | — | — |
| Research Site | Warwick | Rhode Island | — | — |
| Research Site | Columbia | South Carolina | — | — |
| Research Site | Ninety Six | South Carolina | — | — |
| Research Site | Summerville | South Carolina | — | — |
| Research Site | Sioux Falls | South Dakota | — | — |
| Research Site | Arlington | Texas | — | — |
| Research Site | Corpus Christi | Texas | — | — |
| Research Site | Dallas | Texas | — | — |
| Research Site | Lubbock | Texas | — | — |
| Research Site | North Richland Hills | Texas | — | — |
| Research Site | San Antonio | Texas | — | — |
| Research Site | Salt Lake City | Utah | — | — |
| Research Site | Falls Church | Virginia | — | — |
| Research Site | Norfolk | Virginia | — | — |
| Research Site | Richmond | Virginia | — | — |
| Research Site | Edmonds | Washington | — | — |
| Research Site | Renton | Washington | — | — |
| Research Site | Huntington | West Virginia | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 20 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00280865, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 31, 2006 · Synced Oct 20, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00280865 live on ClinicalTrials.gov.